Literature DB >> 31285679

Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National Cancer Database.

M J Passeri1, E H Baker1, I A Siddiqui1, M A Templin2, J B Martinie1, D Vrochides1, D A Iannitti1.   

Abstract

Introduction: Total pancreatectomy for pancreatic ductal adenocarcinoma has historically been associated with substantial patient morbidity and mortality. Given advancements in perioperative and postoperative care, evaluation of the surgical treatment options for pancreatic adenocarcinoma should consider patient outcomes and long-term survival for total pancreatectomy compared with partial pancreatectomy.
Methods: The U.S. National Cancer Database was queried for patients undergoing total pancreatectomy or partial pancreatectomy for pancreatic adenocarcinoma during 1998-2006. Demographics, tumour characteristics, operative outcomes, 30-day mortality, 30-day readmission, additional treatment, and Kaplan-Meier survival curves were compared.
Results: The database query returned 807 patients who underwent total pancreatectomy and 5840 who underwent partial pancreatectomy. More patients who underwent total pancreatectomy than a partial pancreatectomy had a margin-negative resection (p < 0.0001). Mortality and readmission rates were similar in the two groups, as was long-term survival on Kaplan-Meier curves (p = 0.377). A statistically significant difference in the rate of surgery only (without additional treatment) was observed for patients in the total pancreatectomy group (p = 0.0003). Conclusions: Although total compared with partial pancreatectomy was associated with a higher rate of margin-negative resection, median survival was not significantly different for patients undergoing either procedure. Patients who underwent total pancreatectomy were significantly less likely to receive adjuvant therapy.

Entities:  

Keywords:  Pancreatectomy; databases; morbidity; mortality; pancreatic neoplasms; pancreaticoduodenectomy; postoperative care

Year:  2019        PMID: 31285679      PMCID: PMC6588066          DOI: 10.3747/co.26.4066

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  28 in total

Review 1.  Meta-analysis of radical resection rates and margin assessment in pancreatic cancer.

Authors:  M D Chandrasegaram; D Goldstein; J Simes; V Gebski; J G Kench; A J Gill; J S Samra; N D Merrett; A J Richardson; A P Barbour
Journal:  Br J Surg       Date:  2015-09-09       Impact factor: 6.939

2.  Greater lymph node retrieval and lymph node ratio impacts survival in resected pancreatic cancer.

Authors:  Katelin A Mirkin; Christopher S Hollenbeak; Joyce Wong
Journal:  J Surg Res       Date:  2017-07-24       Impact factor: 2.192

3.  Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.

Authors:  David A Kooby; Neha L Lad; Malcolm H Squires; Shishir K Maithel; Juan M Sarmiento; Charles A Staley; N Volkan Adsay; Bassel F El-Rayes; Sharon M Weber; Emily R Winslow; Clifford S Cho; Kathryn A Zavala; David J Bentrem; Mark Knab; Syed A Ahmad; Daniel E Abbott; Jeffrey M Sutton; Hong Jin Kim; Jen Jen Yeh; Rachel Aufforth; Charles R Scoggins; Robert C Martin; Alexander A Parikh; Jamie Robinson; Yassar M Hashim; Ryan C Fields; William G Hawkins; Nipun B Merchant
Journal:  Ann Surg       Date:  2014-09       Impact factor: 12.969

Review 4.  Total pancreatectomy: indications, operative technique, and results: a single centre experience and review of literature.

Authors:  Riccardo Casadei; Francesco Monari; Salvatore Buscemi; Marco Laterza; Claudio Ricci; Daniela Rega; Marielda D'Ambra; Raffaele Pezzilli; Lucia Calculli; Donatella Santini; Francesco Minni
Journal:  Updates Surg       Date:  2010-08

5.  The anatomic location of pancreatic cancer is a prognostic factor for survival.

Authors:  Avo Artinyan; Perry A Soriano; Christina Prendergast; Tracey Low; Joshua D I Ellenhorn; Joseph Kim
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 6.  Surgery for Pancreatic Cancer.

Authors:  Thomas E Clancy
Journal:  Hematol Oncol Clin North Am       Date:  2015-05-30       Impact factor: 3.722

7.  Is there still a role for total pancreatectomy?

Authors:  Michael W Müller; Helmut Friess; Jörg Kleeff; Rolf Dahmen; Markus Wagner; Ulf Hinz; Daniela Breisch-Girbig; Güralp O Ceyhan; Markus W Büchler
Journal:  Ann Surg       Date:  2007-12       Impact factor: 12.969

8.  Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer.

Authors:  Ryan P Merkow; Karl Y Bilimoria; James S Tomlinson; Jennifer L Paruch; Jason B Fleming; Mark S Talamonti; Clifford Y Ko; David J Bentrem
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

Review 9.  Management of pancreatogenic diabetes: challenges and solutions.

Authors:  Jana Makuc
Journal:  Diabetes Metab Syndr Obes       Date:  2016-08-25       Impact factor: 3.168

Review 10.  Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.

Authors:  Daniel de la Iglesia-García; Wei Huang; Peter Szatmary; Iria Baston-Rey; Jaime Gonzalez-Lopez; Guillermo Prada-Ramallal; Rajarshi Mukherjee; Quentin M Nunes; J Enrique Domínguez-Muñoz; Robert Sutton
Journal:  Gut       Date:  2016-12-09       Impact factor: 23.059

View more
  5 in total

1.  Preoperative diabetes complicates postsurgical recovery but does not amplify readmission risk following pancreatic surgery.

Authors:  Mohammad Hosny Hussein; Eman Ali Toraih; Adin Reisner; Areej Shihabi; Zaid Al-Quaryshi; Jeffrey Borchardt; Emad Kandil
Journal:  Gland Surg       Date:  2022-04

2.  Long-term effects of total vs. partial pancreatectomy among patients with pancreatic cancer: a population-based study.

Authors:  Zhiwen Yang; Qiang Tao; Salamu Mijiti; Dandong Luo; Xiang Tang; Jia Liu; Lingmin Jiang; Zonghao Liu; Chen Liang; Xinyue Tu; Peng Zhao; Andreas Minh Luu; Francesco Serra; Roberta Gelmini; Yong Wang; Yun Zheng
Journal:  Ann Transl Med       Date:  2022-05

3.  The Safety and Feasibility of Enhanced Recovery after Surgery in Patients Undergoing Pancreaticoduodenectomy: An Updated Meta-Analysis.

Authors:  You-Meng Sun; Ying Wang; Yi-Xin Mao; Wei Wang
Journal:  Biomed Res Int       Date:  2020-05-08       Impact factor: 3.411

4.  Can Elderly Patients With Pancreatic Cancer Gain Survival Advantages Through More Radical Surgeries? A SEER-Based Analysis.

Authors:  Danna Xie; Baolin Qian; Jing Yang; Xinya Peng; Yinghua Li; Teng Hu; Simin Lu; Xiaojing Chen; Yunwei Han
Journal:  Front Oncol       Date:  2020-10-29       Impact factor: 6.244

Review 5.  The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy.

Authors:  Daniel R Principe; Patrick W Underwood; Murray Korc; Jose G Trevino; Hidayatullah G Munshi; Ajay Rana
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.